Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025American Journal of Translational Research

Clinical efficacy of azithromycin-budesonide combination therapy in pediatric Mycoplasma pneumoniae pneumonia

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBin WuXSXia-mei SongDYDan Yang

Discussion

Loading...

Member takes

Overview

Retrospective cohort analysis shows improved clinical outcomes in pediatric pneumonia patients, suggesting the benefits of combined therapy.

Key Points

  • The combination of azithromycin and budesonide significantly improves clinical response rates in pediatric patients.
  • Participants receiving dual therapy exhibited accelerated symptom resolution and enhanced quality of life compared to the control group.
  • Key predictors for treatment outcomes include disease duration and pre-treatment immunoglobulin and inflammatory marker levels.
  • There were no significant differences in adverse events between the observation and control groups, ensuring treatment safety.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/68c23e4fb210217d64791d24https://doi.org/10.62347/uffc4110
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and safety of nebulized drugs in the treatment of non-severe mycoplasma pneumoniae pneumonia in children - a network meta-analysis2025
  2. 2Comparison Of Inflammatory Control And Safety By Timing Of Doxycycline-Azithromycin Dual Therapy In Pediatric Mycoplasmal Pneumonia2025
  3. 3Efficacy of systemic glucocorticoids in pediatric Mycoplasma pneumoniae infection2025
  4. 4Combination Therapy In Pediatric Bronchitis: Examining Mucolytic, Bronchodilator And Anti-Inflammatory Drug Effects On Secretion Management And Recovery Time2025
  5. 5Macrolide-Resistant Mycoplasma pneumoniae Infection Successfully Treated With Doxycycline and Immunomodulators in a Pediatric Patient: A Case Report2025